Aytu BioScience's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Aytu BioScience is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.64. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 22.93M	$ 22.10M	$ 30.73M	$ 22.73M	$ 26.28M
Gross Profit	$ 16.20M	$ 14.78M	$ 18.56M	$ 12.74M	$ 17.29M
EBIT	$ 608.00K	$ -8.12M	$ 432.00K	$ -7.90M	$ -6.69M
EBITDA	$ 2.94M	$ -5.74M	$ 2.69M	$ -5.61M	$ -4.35M
Net Income Common Stockholders	$ -220.00K	$ -8.12M	$ 2.25M	$ -9.77M	$ -6.69M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 19.53M	$ 19.96M	$ 22.98M	$ 19.18M	$ 19.50M
Total Assets	$ 131.25M	$ 132.89M	$ 136.43M	$ 147.17M	$ 141.44M
Total Debt	$ 16.04M	$ 16.12M	$ 16.36M	$ 25.09M	$ 22.05M
Net Debt	$ -3.49M	$ -3.85M	$ -6.62M	$ 5.92M	$ 2.55M
Total Liabilities	$ 98.40M	$ 100.72M	$ 97.11M	$ 106.30M	$ 95.62M
Stockholders Equity	$ 32.85M	$ 32.17M	$ 39.39M	$ 40.88M	$ 45.82M
Cash Flow	-
Free Cash Flow	$ -100.00K	$ -200.00K	$ 9.41M	$ -2.89M	$ -2.50M
Operating Cash Flow	$ -100.00K	$ -200.00K	$ 9.41M	$ -2.89M	$ -2.50M
Investing Cash Flow	$ -174.00K	$ -76.00K	$ -155.00K	$ 1.00K	$ -5.00K
Financing Cash Flow	$ -126.00K	$ -2.73M	$ -5.40M	$ 2.58M	$ -1.86M

Currency in USD

Aytu BioScience Earnings and Revenue History

Income Statement >

Aytu BioScience Debt to Assets

Balance Sheet >

Aytu BioScience Cash Flow

Cash Flow >

Aytu BioScience Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing